Molecule intelOpportunity: StrongEssential

Aciclovir

14 brands · 8 companies · product forms

ATC: D06BB03, J05AB01, S01AD03

Opportunity snapshot

Launch attractiveness
51
Market saturation
22
Price room
100
Regulatory risk
0
14
brands
8
companies
Rs 467.14
median price
28
price points
20.66x
price spread
100
confidence %

Who competes here

Top companies by brand count · leader share 29%

Price room

Across observed sources and strengths
CheapestRs 100
MedianRs 467.14
Most expensiveRs 2,066.36
Spread20.66×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 20.66x across 28 trusted points (Rs 100.0-2066.36). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 2 live products for Aciclovir — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(100) + 20% low-competition(78) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

8 canonical companies and 14 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 20.66x across 28 trusted points (Rs 100.0-2066.36). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this strong opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.